US Patent Issued to Harpoon Therapeutics on Jan. 20 for "Single domain serum albumin binding protein" (California Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,859, issued on Jan. 20, was assigned to Harpoon Therapeutics Inc. (Rahway, N.J.).

"Single domain serum albumin binding protein" was invented by Robert B. Dubridge (Belmont, Calif.), Bryan D. Lemon (Mountain View, Calif.), Richard J. Austin (San Francisco), Luke Evnin (San Francisco) and Jeanmarie Guenot (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are single domain serum albumins binding proteins with improved thermal stability, binding affinities, and robust aggregation profiles. Also described are multispecific binding proteins comprising a single domain serum albumin binding protein according to the instant discl...